Eastgate Biotech Corp.
ETBI
$0.0045
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | 23.10K | 114.50K | -- | -- | 1.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.10K | 114.50K | -- | -- | 1.70K |
| Cost of Revenue | 92.30K | 56.90K | -- | -- | -- |
| Gross Profit | -69.20K | 57.60K | -- | -- | -- |
| SG&A Expenses | 1.66M | 435.60K | 738.70K | 405.50K | 317.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.74M | 587.00K | 914.70K | 526.20K | 433.50K |
| Operating Income | -1.72M | -472.50K | -914.70K | -526.20K | -433.50K |
| Income Before Tax | -1.63M | -714.80K | -952.10K | -569.20K | -473.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.63M | -714.80K | -952.10K | -569.20K | -473.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.63M | -714.80K | -952.10K | -569.20K | -473.30K |
| EBIT | -1.72M | -472.50K | -914.70K | -526.20K | -433.50K |
| EBITDA | -1.70M | -- | -- | -512.60K | -420.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.11B | 574.21M | 318.07M | 307.84M | 306.27M |
| Average Diluted Shares Outstanding | 1.11B | 574.21M | 318.07M | 307.84M | 306.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |